Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans.

por Jauhar, S, Veronese, M, Rogdaki, M, Bloomfield, M, Natesan, S, Turkheimer, F, Kapur, S, Howes, O D
Publicado 2017

Correction: Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans

por Jauhar, S., Veronese, M., Rogdaki, M., Bloomfield, M., Natesan, S., Turkheimer, F., Kapur, S., Howes, O. D.
Publicado 2018

Correction: Regulation of dopaminergic function: An [(18)F]-DOPA PET apomorphine challenge study in humans

por Jauhar, S, Veronese, M, Rogdaki, M, Bloomfield, M, Natesan, S, Turkheimer, F, Kapur, S, Howes, O D
Publicado 2019

Building a qualitative systems map: applying systems thinking to the commercial determinants of health and industry influence on health policy

por Bertscher, A, Nobles, J, Zatonski, M, Van Den Akker, A, Dance, S, Bondy, K, Gilmore, A, Bloomfield, M
Publicado 2022

Salience attribution and its relationship to cannabis-induced psychotic symptoms

por Bloomfield, M. A. P., Mouchlianitis, E., Morgan, C. J. A., Freeman, T. P., Curran, H. V., Roiser, J. P., Howes, O. D.
Publicado 2016

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

por Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., Nutt, D. J.
Publicado 2017

A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment

por Cornelison, R. C., Yuan, J. X., Tate, K. M., Petrosky, A., Beeghly, G. F., Bloomfield, M., Schwager, S. C., Berr, A. L., Stine, C. A., Cimini, D., Bafakih, F. F., Mandell, J. W., Purow, B. W., Horton, B. J., Munson, J. M.
Publicado 2022